approval
saveSOLIQUA 100/33 (INSULIN GLARGINE) — FDA approval
community read0 votes
Sponsor: SANOFI-AVENTIS US. Form: SOLUTION. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalSOLIQUA 100/33 (INSULIN GLARGINE) — FDA approvalMar 12, 2026 · 204d ago
- approvalSOLIQUA 100/33 (INSULIN GLARGINE) — FDA approvalNov 1, 2024 · 700d ago
- approvalSOLIQUA 100/33 (INSULIN GLARGINE) — FDA approvalSep 28, 2023 · 1100d ago
- approvalSOLIQUA 100/33 (INSULIN GLARGINE) — FDA approvalJun 10, 2022 · 1575d ago
- approvalSOLIQUA 100/33 (INSULIN GLARGINE) — FDA approvalJul 28, 2021 · 1892d ago
- approvalSOLIQUA 100/33 (INSULIN GLARGINE) — FDA approvalNov 15, 2019 · 2513d ago
- approvalSOLIQUA 100/33 (INSULIN GLARGINE) — FDA approvalNov 15, 2019 · 2513d ago
- approvalSOLIQUA 100/33 (INSULIN GLARGINE) — FDA approvalFeb 27, 2019 · 2774d ago
same company · ±60 days · 1
🐶 often sniffed alongside
top 8- tagApproval24 co-mentions · 12 sources
- drugSOLIQUA 100/3324 co-mentions · 12 sources
- druginsulin glargine LA12 co-mentions · 12 sources
- drug(insulin glargine + lixisenatide)12 co-mentions · 12 sources
- drugAbasaglar12 co-mentions · 12 sources
- druginsulin12 co-mentions · 12 sources
- company$SNYSanofi12 co-mentions · 12 sources
- company$SNYNFSanofi12 co-mentions · 12 sources
comments(0)
5-min edit window · permanent after that